Notice2023-18369
Notice of Award of a Single-Source Cooperative Agreement To Fund icddr,b (International Centre for Diarrhoeal Disease Research, Bangladesh)
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
August 25, 2023
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces the award of approximately $6,000,000, for Year 1 funding to icddr,b. The award will support high quality public health research and surveillance activities to further strengthen the ability of the Government of Bangladesh and other global partners to detect, prevent, and respond to disease threats. Funding amounts for years 2-5 will be set at continuation.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 164 (Friday, August 25, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 164 (Friday, August 25, 2023)]
[Notices]
[Page 58281]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-18369]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Award of a Single-Source Cooperative Agreement To Fund
icddr,b (International Centre for Diarrhoeal Disease Research,
Bangladesh)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), located
within the Department of Health and Human Services (HHS), announces the
award of approximately $6,000,000, for Year 1 funding to icddr,b. The
award will support high quality public health research and surveillance
activities to further strengthen the ability of the Government of
Bangladesh and other global partners to detect, prevent, and respond to
disease threats. Funding amounts for years 2-5 will be set at
continuation.
DATES: The period for this award will be September 30, 2024 through
September 29, 2029.
FOR FURTHER INFORMATION CONTACT: Lata Kumar, Global Health Center,
Centers for Disease Control and Prevention, Atlanta, GA, 30033,
Telephone: 404-639-7618, email: <a href="/cdn-cgi/l/email-protection#38545d530f785b5c5b165f574e"><span class="__cf_email__" data-cfemail="1478717f23547770773a737b62">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: The single-source award will support high
quality public health and implementation science research that will
guide stakeholders to prioritize resources, develop policies, and
implement practices and interventions that will help mitigate the
impact of health threats on the Bangladeshi population and globally.
icddr,b is in a unique position to conduct this work, as it is the only
non-diplomatic partner that CDC is aware of that has the legal
authority and operational expertise to process the import of laboratory
supplies and reagents, including time sensitive reagents. Surveillance
activities contemplated under this award detect and isolate high-
consequence pathogens whose handling and storage require advanced
biocontainment skills and capacity. icddr,b's clinical microbiology
laboratory meets the international standards of quality and is ISO
15189-2012 accredited and the institute has a strong and active
institutional biosafety committee and Senior Biosafety Officer. icddr,b
is the most biosafety capable institution in the country to execute
critical ongoing studies on pathogens having pandemic potential such as
Nipah virus, the testing of human, avian and bovine surveillance
samples with unknown etiology, and studies of C. auris and influenza.
To CDC's knowledge, icddr,b is the only institution in Bangladesh with
the capability to handle such pathogens according to international
biosecurity standards. Furthermore, icddr,b has agreements with major
biomedical transportation organizations and maintains a material
transfer agreement (MTA) with CDC for the shipping of swabs, blood,
serum and DNA.
Summary of the Award
Recipient: icddr,b (International Centre for Diarrhoeal Disease
Research, Bangladesh).
Purpose of the Award: The purpose of this award is to further
strengthen the ability of the Government of Bangladesh and other global
partners to detect, prevent, and respond to disease threats through
high quality public health research and surveillance activities.
Specifically, the individual activities under this cooperative
agreement will: (a) determine burden, trends, etiology, and risk
factors of priority diseases in Bangladesh, (b) develop and evaluate
interventions and diagnostics, (c) evaluate the effectiveness of
vaccinations to inform global policy, and (d) strengthen the Government
of Bangladesh's surveillance, laboratory, and outbreak response
capacity.
Amount of Award: The approximate year 1 funding amount will be
$6,000,000 in Federal Fiscal Year (FY) 2024 funds, subject to the
availability of funds. Funding amounts for years 2-5 will be set at
continuation.
Authority: This program is authorized under section 301(a) of the
Public Health Service Act [42 U.S.C. 241(a)], as amended and section
307 of the Public Health Service Act [42 U.S.C. 242l].
Period of Performance: September 30, 2024 through September 29,
2029.
Dated: August 22, 2023.
Terrance Perry,
Chief Grants Management Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2023-18369 Filed 8-24-23; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on August 25, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.